GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BRAIN Biotech AG (XTER:BNN) » Definitions » Book Value per Share

BRAIN Biotech AG (XTER:BNN) Book Value per Share : €0.84 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is BRAIN Biotech AG Book Value per Share?

BRAIN Biotech AG's book value per share for the quarter that ended in Mar. 2024 was €0.84.

During the past 12 months, BRAIN Biotech AG's average Book Value Per Share Growth Rate was -26.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -1.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of BRAIN Biotech AG was 45.40% per year. The lowest was -26.30% per year. And the median was 4.60% per year.

BRAIN Biotech AG's current price is €2.77. Its book value per share for the quarter that ended in Mar. 2024 was €0.84. Hence, today's PB Ratio of BRAIN Biotech AG is 3.29.

During the past 9 years, the highest P/B Ratio of BRAIN Biotech AG was 24.64. The lowest was 3.22. And the median was 8.21.

Good Sign:

BRAIN Biotech AG stock PB Ratio (=3.31) is close to 10-year low of 3.22


BRAIN Biotech AG Book Value per Share Historical Data

The historical data trend for BRAIN Biotech AG's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BRAIN Biotech AG Book Value per Share Chart

BRAIN Biotech AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only 0.85 1.05 1.78 1.36 1.00

BRAIN Biotech AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.15 1.07 1.00 0.88 0.84

Competitive Comparison of BRAIN Biotech AG's Book Value per Share

For the Specialty Chemicals subindustry, BRAIN Biotech AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BRAIN Biotech AG's PB Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, BRAIN Biotech AG's PB Ratio distribution charts can be found below:

* The bar in red indicates where BRAIN Biotech AG's PB Ratio falls into.



BRAIN Biotech AG Book Value per Share Calculation

BRAIN Biotech AG's Book Value Per Share for the fiscal year that ended in Sep. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(21.77-0.00)/21.85
=1.00

BRAIN Biotech AG's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(18.41-0.00)/21.85
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


BRAIN Biotech AG  (XTER:BNN) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


BRAIN Biotech AG Book Value per Share Related Terms

Thank you for viewing the detailed overview of BRAIN Biotech AG's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BRAIN Biotech AG (XTER:BNN) Business Description

Traded in Other Exchanges
Address
Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673
BRAIN Biotech AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. The company's segments include, BioProducts, BioScience and BioIncubator. Majority of the revenue is generated from its BioProducts segment which comprises of the product business with enzymes and other proteins for specific segments of the food industry. Geographically, the company generates majority of the revenue from United States of America and also has presence in other markets such as, Germany, France, United Kingdom and Netherlands.
Executives
Dr. Michael Majerus Supervisory Board
Dr. Georg Kellinghusen Supervisory Board
Michael Schneiders Board of Directors
Adriaan Moelker Board of Directors
Lukas Linnig Board of Directors

BRAIN Biotech AG (XTER:BNN) Headlines

No Headlines